Clinical Trial Details
— Status: Recruiting
Administrative data
| NCT number |
NCT05763498 |
| Other study ID # |
JZ OO |
| Secondary ID |
|
| Status |
Recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
February 24, 2023 |
| Est. completion date |
July 31, 2025 |
Study information
| Verified date |
March 2023 |
| Source |
Centro Hospitalar Lisboa Norte |
| Contact |
Isabel B Pereira, M.D. |
| Phone |
+351967053610 |
| Email |
isabelsofiapereira[@]yahoo.com |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
The junctional zone (JZ) is an internal layer of the myometrium, with unique characteristics
that allow its visualization as a hypoechogenic structure in three-dimensional (3D)
ultrasound.
While there is a growing realization that the origins of major obstetrical complications
associated with defective deep placentation, such as pre-term labour, fetal growth
restriction and pre-eclampsia, may lie in the very early pregnancy events, the underlying
mechanisms are not understood.
Description:
During pregnancy, unique vascular changes occur, associated with decidualization of the
maternal tissues in response to trophoblast invasion, first in the endometrium and
subsequently in the myometrial JZ. The JZ broadly represents the inner third of the
myometrium that, together with its overlying endometrium, is involved in placentation.
Defective deep placentation, defined by the absent or incomplete remodelling of the JZ
segment of the spiral arteries, may be associated with a spectrum of obstetrical
complications, ranging from late miscarriage and pre-term labour to fetal growth restriction
and pre-eclampsia.
Thus, the primary site of vascular pathology in pregnancies lies not in the placenta or
decidua but in the JZ. To understand how impaired remodelling of the myometrial JZ prior to
conception may predispose to subsequent defective deep placentation, it is important to first
describe the structural and functional changes in the JZ at the time of embryo implantation,
and subsequently analyse the distinguishing features of defective deep placentation
associated with different pregnancy disorders.
Thus, non-invasive assessment of the JZ prior to conception may turn out to be useful in
identifying those women at risk of major obstetrical complications.
This project aims to evaluate the relationship between the characteristics of the ZJ in 3D
ultrasound, and major adverse obstetrical outcomes in assisted reproductive technology (ART)
treatments, namely in vitro fertilization cycles, intracytoplasmic sperm injection and frozen
embryo transfer (FET).
In a prospective and observational study with the inclusion of 200 cases, a 3D ultrasound
will be performed on the day on which the final oocyte maturation is triggered or, on FET, on
the day prior to the administration of progesterone.
After the quality of visualization of the JZ is classified, its thickness will be measured
and described as regular, irregular or interrupted.
The volume of the ZJ will be obtained by subtracting the endometrial volume from the volume
of the junctional zone and the endometrium.
These characteristics will be related to major obstetrical adverse outcomes: pre-eclampsia,
pre-term labour and fetal growth restriction. The relation with a high-risk first trimester
screening for pre-eclampsia will also be accessed.
After explaining the study and obtaining written consent, a 3D ultrasound will be performed
for uterine evaluation, on the day of the final oocyte maturation trigger in cases of IVF /
ICSI. In cases of FET, the ultrasound evaluation will be carried out on the day before the
start of the luteal phase support.
All ultrasounds will be performed in a standardized manner by the same operator. With an
empty bladder, in a lithotomy position, a 2D transvaginal ultrasound will be performed using
a GE Voluson 730 Expert® ultrasound, with an endovaginal probe with a 4-8MHz frequency.
Identification of endometriosis lesions or acquired uterine abnormalities such as leiomyomas
or adenomyosis will be exclusion criteria. After evaluating the number and maximum dimension
of the ovarian follicles and the endometrial thickness, the three-dimensional volume box will
be placed to encompass the entire uterus in longitudinal section, with minimal inclusion of
para-uterine structures. A maximum acquisition angle of 90º and maximum quality will be used.
To minimize artifacts, during the acquisition both the probe and the woman must remain
immobile, being asked to hold their breath. Then, a three-dimensional volume will be
generated by automatic 360º rotation of the transducer. For each case, two volumes will
always be obtained.
